The purpose of this clinical trial is to evaluate the effectiveness and safety of the multifocal Artiflex Presbyopic (Artiplus) intraocular lens.
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Improvement in monocular and binocular uncorrected near visual acuity (UNVA)
Timeframe: 3 years
Improvement in monocular and binocular corrected near visual acuity (CNVA)
Timeframe: 3 years
Improvement in monocular and binocular distance corrected near visual acuity (DCNVA)
Timeframe: 3 years
Improvement in monocular and binocular uncorrected intermediate visual acuity (UIVA)
Timeframe: 3 years
Improvement in monocular and binocular distance corrected intermediate visual acuity (DCIVA)
Timeframe: 3 years
Improvement in monocular and binocular uncorrected distance visual acuity (UDVA)
Timeframe: 3 years
Improvement in monocular and binocular corrected distance visual acuity (CDVA)
Timeframe: 3 years
Defocus evaluation
Timeframe: 3 years
Predictability of the manifest refraction spherical equivalent (MRSE)
Timeframe: 3 years
Predictability of the manifest refraction spherical equivalent (MRSE)
Timeframe: 3 years
Predictability of the manifest refraction spherical equivalent (MRSE)
Timeframe: 3 years
Stability of manifest refraction spherical equivalent (MRSE)
Timeframe: 3 years
Stability of manifest refraction spherical equivalent (MRSE)
Timeframe: 3 years
Stability of manifest refraction spherical equivalent (MRSE)
Timeframe: 3 years
Evaluation of visual disturbances using a validated questionnaire
Timeframe: 3 years
Evaluation of visual disturbances using a validated questionnaire
Timeframe: 3 years
Evaluation of visual disturbances using a validated questionnaire
Timeframe: 3 years
Evaluation of visual disturbances using a validated questionnaire
Timeframe: 3 years
Evaluation of visual disturbances using a validated questionnaire
Timeframe: 3 years
Satisfaction questionnaire
Timeframe: 3 years
Endothelial cell density
Timeframe: 3 years
Endothelial cell density
Timeframe: 3 years
Endothelial cell density
Timeframe: 3 years
Adverse event (AEs) / complication rates
Timeframe: 3 years